RENNAISO Trademark

Trademark Overview

On Monday, August 2, 2004, a trademark application was filed for RENNAISO with the United States Patent and Trademark Office. The USPTO has given the RENNAISO trademark a serial number of 78460435. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, February 11, 2005. This trademark is owned by Pfizer Inc.. The RENNAISO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; central nervous system and neurological diseases and disorders; sleep disorders; urological diseases and disorders; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; and hemolytic diseases and disorders; pharmaceutical preparations, namely, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations; smoking cessation preparations, tissue and skin repair preparations and gynecological preparations
rennaiso

General Information

Serial Number78460435
Word MarkRENNAISO
Filing DateMonday, August 2, 2004
Status601 - ABANDONED - EXPRESS
Status DateFriday, February 11, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases and disorders; central nervous system and neurological diseases and disorders; sleep disorders; urological diseases and disorders; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; and hemolytic diseases and disorders; pharmaceutical preparations, namely, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations; smoking cessation preparations, tissue and skin repair preparations and gynecological preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 11, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, February 11, 2005ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Friday, February 11, 2005ABANDONMENT - EXPRESS MAILED
Friday, February 11, 2005TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, February 10, 2005NON-FINAL ACTION E-MAILED
Thursday, February 10, 2005NON-FINAL ACTION WRITTEN
Saturday, February 5, 2005ASSIGNED TO EXAMINER
Wednesday, August 11, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

rennaiso disorders diseases preparations pharmaceutical sexual dysfunction hemolytic erectile diabetes allergies